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Abstract
The electrocardiographic interval between the peak and the end of the T-wave (Tpe) is believed to be an arrhythmic risk marker. However, there are also a number 
of reports that are inconsistent with the usefulness of Tpe for identifying abnormal repolarization. This study was designed to investigate how the Tpe prolongation 
is correlated to a prolonged QT interval, induced by IKr-blockers. The study included two data sets. A first group of 21 healthy subjects received 160 mg and 320 mg 
doses of d,l-sotalol. The second group, of 40 patients with schizophrenia, was switched to 16 mg sertindole treatment. The Fridericia corrected QT prolongations 
(QTcF) and the mean Tpe changes (∆Tpe) were: d,l-sotalol 160 mg: ∆QTcF=29 ms & ∆Tpe=4.7 ms, 320 mg: ∆QTcF=51 ms & ∆Tpe=6.2 ms, sertindole 16 mg: 
∆QTcF=17 ms & ∆Tpe=8.5 ms. There were low correlations (r) between ∆QTcF and ∆Tpe in both d,l-sotalol groups and sertindole group.
Given the lack of linear relationship between Tpe and QT in response to potential torsadogenic drugs, this study raises doubt about the usefulness of Tpe as a 
biomarker for repolarization changes and torsadogenic potential in drug safety studies. 
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Introduction
Features of the morphology of the T-wave of the body surface 
electrocardiogram (ECG) can reflect abnormalities of ventricular 
repolarization. For example, the T-wave peak-to-end (Tpe), which is 
defined as the interval from the peak of the T-wave to the end of the 
T-wave, may be a relatively simple marker for observing repolarization 
changes and identifying drugs with torsadogenic potential. 
There is some evidence suggesting that a prolonged Tpe interval 
represents repolarization heterogeneity and that the interval may be a 
marker of arrhythmogenesis [1-4].  The prolonged Tpe interval might 
be associated with a high risk for developing torsades de pointes (TdP) 
in patients with acquired and congenital long QT syndromes (LQTS). 
The Tpe interval can also be prolonged in patients with a history of 
drug-related TdP [5-11]. 
However, there are also a number of reports about inconsistencies 
of the Tpe interval as a sensitive biomarker for identifying abnormal 
repolarization [8,12-18]. Importantly, these reports show that the 
clinical usefulness of the Tpe interval for identifying patients at risk of 
ventricular arrhythmias is still far from being established. 
The Tpe interval was proposed to quantify transmural dispersion 
of repolarization (TDR), based on results from the wedge preparation 
obtained from the free wall of the canine left ventricle [19]. The 
measure of dispersion was based on differences in the action potential 
durations (APD) of the principal layers that comprise the ventricular 
myocardium.  It was demonstrated in this setting that the peak of the 
T-wave coincided with the end of epicardial repolarization, whereas 
the end of the T-wave coincided with the end of repolarization of the 
mid-mural M cells. Therefore, by testing, e.g., d-sotalol, a known QT 
prolonging drug, Antzelevitch et al., showed that longer APDs in the M 
cells with relatively shorter APDs in endocardial and epicardial layers 
lead to Tpe prolongation [20,21]. 
In the case of more complex T-waves, including negative, biphasic 
and triphasic ones, it was suggested that the estimation of TDR could 
be based on the interval from the nadir of the T-wave to the end of the 
T-wave instead of the interval from the peak of the T-wave to the end 
of the T-wave [22]. However, the representation of TDR in the ECG is 
a controversial subject [23,24].
The Tpe to QT interval ratio (Tpe/QT) has also been proposed to 
provide an estimate of dispersion of repolarization. This measurement 
estimates the Tpe interval relative to the total duration of activation and 
repolarization and since the QT interval varies with heart rate, the Tpe/
QT ratio could also be less heart rate dependent than Tpe itself [25]. 
The Tpe/QT ratio has thus been suggested as a more sensitive index 
of repolarization changes and risk of arrhythmia compared to the Tpe 
interval alone. However, in one study of the Tpe interval we showed 
that Tpe was heart rate dependent but the effect of rate was only minor 
at near resting heart rates [16]. We have also shown that, despite QTc 
prolonging effects of sertindole, no increase in the duration of the Tpe 
interval was found [18]. In addition, we have shown that in patients 
with the long QT syndrome and elevated risk of TdP, it was not possible 
to use Tpe to distinguish symptomatic from asymptomatic patients 
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[16]. In comparisons of ECG data from survivors and non-survivors of 
cardiovascular disease, Smetana et al., showed that the Tpe interval was 
significantly shorter in non-survivors, both uncorrected and corrected 
for heart rate [15]. Therefore, there are serious problems with a direct 
extrapolation of the findings in vitro about the Tpe interval to clinical 
populations. Particularly, Opthof et al., argued that there are influential 
biological differences between in vitro preparations and the in vivo 
heart, such as autonomic, humoral, and hemodynamic factors [26]. 
In addition, there is a small body of data dealing with the functional 
role of M cells in the human heart. Some data has failed to show the role 
of M cells in effecting Tpe changes [27,28].  According to the studies 
by Opthof et al., the Tpe interval is unlikely to be correlated with TDR 
in vivo [26,29]. These studies conclude that, in general, epicardial 
repolarization occurs later than endocardial repolarization in the free 
wall of the left ventricle. Hence, the functional and clinical importance 
of M cells for Tpe changes in vivo is not clear.
It thus remains controversial what the Tpe interval actually 
represents. However, it is important to quantify the extent to which 
the Tpe interval is correlated with the whole heart repolarization time, 
represented by the QT interval. 
Aim of the study
The present study was designed to examine the association between 
the Tpe interval and QT prolongation induced by two torsadogenic 
drugs: sertindole and d,l-sotalol, both IKr-blockers, capable of inducing 
QT prolongation and TdP [30,31].
Methods
Study population and design
The present study included data from two different IKr-blockers. 
The first group of 39 healthy subjects received 0, 160 mg and 320 mg 
doses of d,l-sotalol on three consecutive days. All subjects were males, 
between 18 and 45 years of age. Their healthy status was confirmed 
by history, physical examination, normal blood pressure and no use 
of concomitant medication. The second group of 37 patients carried a 
WHO ICD-10 diagnosis of schizophrenia. This group was switched to 
16 mg sertindole treatment. The study was approved by the Scientific 
Ethical Committee of Northern Jutland. None of the subjects had a 
history of cardiac diseases and all had normal baseline ECG. In some 
cases the  V5 on ECG data  could not be analysed based on signal 
noise.  Further demographic information on subjects receiving d,l-
sotalol and sertindole can be found in Sarapa et al., Graff et al. and 
Nielsen et al. [32-34].
All subjects gave written informed consent to the study protocol 
approved by an independent Institutional Review Board. All subjects 
gave written informed consent to the study protocol approved by an 
independent Institutional Review Board. All subjects gave written 
informed consent to the study protocol approved by an independent 
Institutional Review Board. All subjects gave written informed consent 
to the study protocol approved by an independent Institutional 
Review Board. All subjects gave written informed consent to the study 
protocol approved by an independent Institutional Review Board. All 
subjects gave written informed consent to the study protocol approved 
by an independent Institutional Review Board. All subjects gave 
written informed consent to the study protocol approved by an 
independent Institutional Review Board. All subjects gave written 
informed consent to the study protocol approved by an independent 
Institutional Review Board.
Written informed consent was obtained from all subjects in the 
first group for the study protocol. However, in the second group 
obtaining informed consent was not required because the study was 
non-interventional and ECG was indicated for therapeutic monitoring.
ECG acquisition 
For d,l-sotalol, ECG segments of 10 s duration were obtained from 
12-lead digital Holter recordings (H12Recorder, Mortara Instrument, 
Milwaukee, WI). ECG recordings at the time of maximum plasma 
concentrations, 3.5 h post-dose were used, both for 160 mg and 320 mg 
d,l-sotalol. The corresponding study time was used on the baseline day. 
Each ECG extracted from Holter was resampled from 180 Hz to 500 Hz 
as previously described [33].
For sertindole, digital ECGs were recorded with GE MAC5000 
and GE Cardiosoft (GE Healthcare, Milwaukee, WI). At baseline five 
consecutive 12-lead digital ECGs of 10 sec duration were recorded from 
each schizophrenia patient at a sample rate of 500 Hz and transferred 
to a MUSE database (GE Healthcare, Milwaukee, WI). ECGs were 
recorded again when patients reached steady-state concentration of 
sertindole 16 mg, after a minimum of 3 weeks as recommended in the 
Summary of Product Characteristics of Serdolect [34].
ECG analysis
From each 10 s ECG recording a median beat was formed in the 
recorded leads using MUSE/Interval Editor software (GE Healthcare, 
Milwaukee, WI). Lead V5 was used to measure the Tpe interval because 
V5 is the lateral precordial lead which is considered to best reflect the 
electrical phenomena in the left ventricle during IKr-blocker-induced 
repolarization disorders. Based on the early studies, lead V5 was 
targeted to measure the Tpeak-Tend interval to predict TdP [5]. Since 
analyses were performed on a median beat, ECGs were not filtered to 
measure Tpeak location.
QT intervals were measured automatically (12SL, GE Healthcare, 
Milwaukee, WI). QT intervals were corrected for heart rate with 
Fridericia’s equation: QTcF=QT/RR1/3.
The peak of the T-wave was defined as the point of highest 
amplitude of the T-wave. In cases of notched or bifid T-waves the 
interval from the nadir, between the peaks of the T-wave, to the end of 
the T-wave was used [20-22].  
Statistical analysis
Data were analyzed using Matlab R2012b (Mathworks Inc, 
Natick, MA). Results are presented as means and standard deviations. 
Pearson’s correlation coefficients were used for investigating linear 
relationships. All findings were compared by Student’s t-test for paired 
data. A p-value <0.05 was considered statistically significant.
Results
ECG characteristics for the sertindole and d,l-sotalol groups are 
outlined in Table 1. The mean Tpe did change significantly from 
baseline with sertindole and for d,l-sotalol 320 mg, but not significantly 
for 160 mg. Also, the QT and QTcF intervals increased significantly 
following both d,l-sotalol and sertindole administration (Figure 1).
A scatter plot for Tpe versus QTcF, for all data, is shown in Figure 
2. Correlation coefficients for the linear relationships are given in 
table 2. The largest correlation coefficient (r) was r=0.45, p=0.005 for 
sertindole, whereas the correlation coefficients for Tpe on QTcF for 
sotalol were small and not significant (160 mg: r=0.15, p=0.54 and 320 
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Figure 1. QT, QTcF and Tpe for d,l-sotalol (left column) and sertindole (right column) Boxplots: median, interquartile range and full range. Mean values are given for each measurement.
Figure 2. Scatter plot for changes in QTcF and Tpe from baseline for sotalol 160 mg (*), sotalol 320 mg (+) and sertindole (o)
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mg: r=0.15, p=0.54). Despite the statistically significant correlation for 
sertindole between QTcF and Tpe, the relationship explains only a 
small percentage (20%) of the variation of Tpe with QTcF.
Discussion
We found that, despite marked QT and QTcF prolongation, induced 
by potential torsadogenic IKr-blockers d,l-sotalol and sertindole, little 
linear association was observed between the Tpe interval and the QTcF 
interval. Tpe changes with a lower significant value (see P-value in Table 
1). Figure 2 shows a high variance of Tpe relative to the drug-induced 
changes and, compared with QTcF, Tpe therefore is not a robust 
predictor of potential torsadogenicity prolonging repolarization.
Our results are not in accordance with a number of previous 
studies [1-11]. On the basis of prolonged Tpe intervals, those studies 
concluded that the Tpe interval can be an important marker of 
arrhythmia susceptibility. However, there is also a number of studies 
that support our findings whether prolongation of the Tpe interval 
can be used to predict the risk of arrhythmia [12-18]. In one case, Tpe 
was even found to be statistically significantly shorter in non-surviving 
cardiovascular patients compared to survivors [15]. 
Our studies on T-wave morphology have shown that, compared 
to the QT interval, T-wave morphology is a more sensitive marker for 
assessing repolarization changes and arrhythmic potential with IKr-
blockers [33-36]. This is not surprising since the electrophysiological 
effects that occur with torsadogenic drugs are expected to have a larger 
effect on T-wave changes and a stronger association with TdP compared 
to the QT interval [37]. In addition, T-wave shape changes are not 
captured by the Tpe interval which measures only the duration of the 
poorly defined final part of repolarization. Interestingly, our recent 
work has proposed the minimal T-wave representation by making 
T-wave independent of QT duration and thus much less dependent 
on heart rate. The results of analyzing the minimal T-wave shape 
showed that it could identify normal from abnormal repolarization 
significantly better compared to heart rate corrected QT interval (QTc) 
and most of the prolongation occurred in the ascending segment of 
the T-wave whereas T-peak to T-end was less sensitive relatively after 
d,l-sotalol [38]. Also, studies of the effects of some IKr blockers on 
multiple sub-intervals of the QT interval showed that hERG potassium 
channel block equally affects the whole T-wave duration, early and 
late repolarization (Tj to Tend and Tpe intervals) whereas additional 
inward current block (calcium or late sodium) preferentially shortens 
early repolarization [39,40]. In addition, Johannesen et al., showed that 
QTc (QTc prolongation in 20 of 26 drugs, P=0.014) is a more sensitive 
biomarker of hERG potassium channel block compared with Tpe (Tpe 
prolongation in 18 of 26 drugs, P=0.051) [40]. The measurement of Tpe 
alone can therefore, not be expected to provide adequate information 
about the complex repolarization changes that occur with torsadogenic 
drugs. 
There are two important sources of error in the Tpe interval. First, 
the end of the T-wave can be difficult to determine, since it may not 
reach the baseline and may be followed by a superimposed U-wave 
or P-wave. This is the same problem as occurs when determining the 
QT interval. Secondly, IKr-blockers may produce considerable T-wave 
changes particularly flatness, notches and asymmetry. The drug-
induced shape changes add to the difficulty of measuring the time of 
occurrence of the peak of the T-wave, which thus has a great influence 
on the assessment of changes of the Tpe interval. Due to the short 
duration of the Tpe interval, those measurement errors will have a 
relatively larger impact on absolute values of the Tpe interval compared 
to the QT interval. This is an undesirable property of the Tpe interval as 
a biomarker for repolarization changes. Finally, the absolute values for 
the Tpe interval is heavily influenced by the method used to measure 
the duration. For example, the tangent method will tend to measure QT 
and Tpe intervals which are shorter compared to the method used in 
this study which estimate the end of the T-wave from superimposition 
of recorded leads. The discrepancy between measuring methods 
explains why studies that do not use the same method for estimating 
the end of the T-wave, can report very different QT and Tpe intervals, 
even on the same data. The discrepancy in measuring technique does 
not explain however, the lack of effect on the Tpe interval in this study, 
despite marked QT interval changes. 
Based on Xia et al., it is not useful to average Tpe as index of TDR, 
among several leads because TDR might vary in different regions of the 
ventricular myocardium under different pathophysiologic conditions 
[41]. Therefore, it is advisable to measure Tpe independently in each 
of the precordial leads. Also, early studies used the V5 lead reflecting 
electrical phenomena in left ventricle to show that the Tpe interval of the 
T-wave loop might be a useful predictor of TdP in long QT syndrome 
(LQTS) patients whose IKr current is (partially) blocked. Consequently, 
in this study lead V5 was targeted to measure the Tpe interval, because 
it could be considered to best reflect the electrical phenomena in the left 
ventricle during IKr-blocker-induced repolarization disorders.
One limitation of the study is that different devices were used 
in the two groups for ECG recording. Also, this study is based on a 
retrospective analysis and that the conclusion should be interpreted 
with appropriate levels of caution.
In conclusion, we have shown much lower effect sizes for drug-
induced changes of Tpe than for QTcF, which implies that QTcF is 
a more robust biomarker for repolarization changes in drug safety 
studies.
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Written informed consent was obtained from all subjects in the 
first group for the study protocol and was approved by the Scientific 
Sertindole Sotalol
Baseline treatment p-value* baseline 160mg p-value 320mg p-value
QT (ms) 378 ± 56 396 ± 71 <0.05 381 ± 35 435 ± 51 <0.001 465 ± 50 <0.001
Tpe (ms) 99 ± 24 107 ± 34 <0.05 92 ± 16 97 ± 19 0.09 98.5 ± 18 <0.05
QTcF (ms) 418 ± 42 435 ± 48 <0.05 402 ± 31 431 ± 39 <0.001 453 ± 43 <0.001
Table 1. ECG characteristics for sertindole and sotalol.
∆QTcF & ∆Tpe Pearson Correlation Coefficient (r) p-value
d,l-sotalol (320mg) 0.15 0.52
d,l-sotalol (160mg) 0.15 0.54
Sertindole (16 mg) 0.45 0.005
Table 2. Pearson’s correlation coefficients between prolongation of QTcF and Tpe intervals.
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Ethical Committee of Northern Jutland. However, in the second group 
obtaining informed consent was not required because the study was 
non-interventional and ECG was indicated for therapeutic monitoring. 
Further demographic information on subjects receiving d,l-sotalol and 
sertindole can be found in Sarapa et al., Graff et al., and Nielsen et al., 
[32-34].
All subjects gave written informed consent to the study protocol 
approved by an independent Institutional Review Board. All subjects 
gave written informed consent to the study protocol approved by an 
independent Institutional Review Board. All subjects gave written 
informed consent to the study protocol approved by an independent 
Institutional Review Board. All subjects gave written informed consent 
to the study protocol approved by an independent Institutional Review 
Board.
All subjects gave written informed consent to the study protocol 
approved by an independent Institutional Review Board. All subjects 
gave written informed consent to the study protocol approved by an 
independent Institutional Review Board. All subjects gave written 
informed consent to the study protocol approved by an independent 
Institutional Review Board. All subjects gave written informed consent 
to the study protocol approved by an independent Institutional Review 
Board.
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